Evidence map›Paper›PMID 22311343›Full record

ArticlePediatric nephrology (Berlin, Germany)2012

Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function.

Justine Bacchetta, Pierre Cochat, Isidro B Salusky, Katherine Wesseling-Perry

Open access · greenAbstract read
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Bone Fragility Fractures in CKD Patients.Calcified tissue international · 2021
    Review
  6. Article
  7. Association between serum uric acid and bone health in adolescents.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Article
  8. Article
  9. Insulin suppresses the production of fibroblast growth factor 23 (FGF23).Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Justine BacchettaCentre de Référence des Maladies Rénales Rares, Service de Néphrologie et Rhumatologie Pédiatriques, Hôpital Femme Mère Enfant, 59 Bd Pinel, 69677, Bron, France. j.bacchetta@laposte.net
Pierre Cochat
Isidro B Salusky
Katherine Wesseling-Perry
University of California, Los Angeles · USHôpital Femme Mère Enfant · FRUniversité Claude Bernard Lyon 1 · FR

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
UCLA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR033176 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2011 to 2011
$15.5M
Regulation of Bone Mineralization in Renal OsteodystrophyR01DK035423 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SALUSKY, ISIDRO B. · 1986 to 2012
$4.9M
ROLE OF PTH IN RENAL OSTEODYSTROPHYR01DK067563 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SALUSKY, ISIDRO B. · 2005 to 2009
$1.9M
FGF-23 Regulation in Chronic Kidney DiseaseK23DK080984 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WESSELING-PERRY, KATHERINE · 2009 to 2013
$872k
NCATS NIH HHS UL1 TR000124NCRR NIH HHS UL1 RR033176NIDDK NIH HHS DK 080984-01A1NIDDK NIH HHS DK 35423NIDDK NIH HHS DK 67563NIDDK NIH HHS K23 DK080984NIDDK NIH HHS R01 DK035423NIDDK NIH HHS R01 DK067563
6 · The paper itself

Abstract

backgroundFibroblast growth factor 23 (FGF23) is a phosphaturic hormone and a suppressor of renal 1α hydroxylase. Although circulating values of FGF23 are increased in early chronic kidney disease (CKD), the interplay between FGF23 levels, growth and nutritional biomarkers has not been evaluated in children with normal renal function.

methodsWe performed a secondary analysis of the cross-sectional observational INU23 study in 98 children (51 boys, mean age 10.5 ± 3.9 years) with preserved renal function (glomerular filtration rate (GFR) 114 ± 14 ml/min/1.73 m(2)).

resultsIn bivariate analyses, C-terminal FGF23 levels were positively related to phosphorus and uric acid levels. Intact FGF23 levels were positively associated with uric acid and insulin growth factor 1 (IGF1) levels, with similar results for age, body mass index (BMI), and 25OH vitamin D (25(OH)D). By multivariable analyses, 25(OH)D, uric acid, and phosphorus were independent predictors of C-terminal FGF23, while 25(OH)D, uric acid, and IGF1 were independent predictors of intact FGF23.

conclusionsIn children with preserved kidney function, the association between FGF23, uric acid, and IGF1 suggests that FGF23 could be an early nutritional indicator of high protein and phosphate intake. The association between FGF23 and IGF1 also suggests a relationship between FGF23 and growth, and warrants further investigation.

Indexed as

ChildCross-Sectional StudiesFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsHumansInsulin-Like Growth Factor IKidneyKidney Function TestsMaleRenal Insufficiency, ChronicUric AcidFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsInsulin-Like Growth Factor IUric Acid

Identifiers

PMID22311343
PMCPMC3793329
OpenAlexW2168227892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.